Menu
Our Pipeline
First in Class Neutrophil Modifying Drug Candidates
Neutrophil Drug Manipulation
| Program | Discovery | Target Validation | In Vivo POC | Lead Selection | CMC | In Vivo CRO | Pre-IND |
|---|---|---|---|---|---|---|---|
|
IMYX-3 IBD
|
|
|
|
|
|
Q3 2024 |
|
|
IMYX-3 COPD
|
|
|
|
|
|
|
|
|
IMYX-5 CANCER
|
|
|
|
||||
Neutrophil Genomic Manipulation
| Program | Discovery | Target Validation | In Vivo POC | Lead Selection | CMC | In Vivo CRO | Pre-IND |
|---|---|---|---|---|---|---|---|
|
IMYX-LNP mRNA1
Orphan
|
|
|
|
|
|
||
